GlassScriptPhysician profile
Rahul Malhotra
NPI 1629079876
$81,662.56
in general payments reported to CMS, 2019-2025
64 companies · $21K in 2025
The $21K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $7,168 · 2021: $5,371 · 2022: $15K · 2023: $6,304 · 2024: $9,375 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Travel and Lodging: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20,467.78 |
| Travel and Lodging | $14,533.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $20,468.31 | 2019-2025 | Indigo System |
| Medtronic, INC. | $16,473.38 | 2021-2025 | Symplicity G3, Resolute Onyx, Micra |
| Angiodynamics, INC. | $15,468.36 | 2019-2024 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $4,871.52 | 2020-2025 | General - Therapies, General - Brady, Ekosonic |
| Veniti, INC. | $4,250.00 | 2019 | |
| Medtronic Vascular, INC. | $2,878.28 | 2019-2020 | |
| Amgen INC. | $2,037.10 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $1,541.29 | 2019-2025 | Amplatzer Amulet, Cardiomems, Esprit |
| Endologix LLC | $1,539.21 | 2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Abiomed | $1,445.27 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $965.67 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $776.22 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $679.39 | 2019-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $584.41 | 2021-2025 | Verquvo |
| Cook Medical LLC | $564.14 | 2019-2025 | Cook, Zilver Vena, Cook Celect |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $554.37 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Pfizer INC. | $543.06 | 2019-2025 | |
| Novo Nordisk INC | $526.84 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $511.65 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $443.26 | 2023-2025 | Assure Wcd |
| Biosense Webster, INC. | $439.56 | 2020-2022 | |
| Tactile Systems Technology INC | $380.68 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Imperative Care, INC | $314.91 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.19 | 2021-2025 | Jardiance |
| Cardinal Health 200 LLC | $284.40 | 2019 | |
| Siemens Medical Solutions USA, INC. | $267.62 | 2020-2025 | Biograph Mct X-4r, Artis Q Ceiling |
| Impulse Dynamics (USA) INC. | $259.27 | 2022-2024 | Optimizer, Optimizer |
| Bardy Diagnostics, INC. | $255.00 | 2019-2021 | |
| Stryker Corporation | $232.12 | 2025 | Limflow System, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $222.54 | 2019-2024 | Xarelto |
| Cvrx, INC. | $195.46 | 2024-2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $193.44 | 2022-2025 | Opsumit, Uptravi |
| Shockwave Medical, INC | $125.00 | 2025 | |
| Asahi Intecc USA, INC. | $119.61 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $101.91 | 2023-2024 | Inpefa |
| Biocompatibles, INC. | $78.36 | 2019 | |
| Amarin Pharma, INC. | $67.58 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $62.64 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $57.36 | 2023-2025 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $48.07 | 2019 | |
| Mimedx Group, INC. | $46.30 | 2025 | |
| Cordis US Corp. | $42.59 | 2022-2025 | |
| Chiesi USA, INC. | $42.16 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $40.44 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $34.83 | 2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Cardiovascular Systems INC. | $31.20 | 2019-2021 | |
| Daiichi Sankyo INC. | $28.36 | 2023 | Injectafer |
| Arbor Pharmaceuticals, INC. | $27.87 | 2020-2022 | |
| Inspire Medical Systems, INC. | $24.81 | 2025 | Inspire |
| Terumo Medical Corporation | $23.09 | 2021 | |
| Venclose INC. | $22.61 | 2020 | |
| Inari Medical, INC. | $20.21 | 2022 | |
| Avinger INC. | $19.98 | 2021 | |
| Esperion Therapeutics, INC. | $19.66 | 2022 | |
| W. L. Gore & Associates, INC. | $18.21 | 2022 | |
| Bard Peripheral Vascular, INC. | $17.44 | 2023 | Venclose Maven Catheter |
| Veryan Medical Incorporated | $17.29 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.15 | 2024 | Edarbi |
| Lilly USA, LLC | $14.80 | 2025 | Mounjaro, Zepbound |
| Vivaquant INC, Dba Rhythm Express | $14.00 | 2024 | Rhythm Express |
| Advanced Oxygen Therapy INC. | $13.19 | 2025 | Topical Oxygen Chamber For Extremities |
| Thrombolex, INC. | $6.92 | 2024 | Bashir Endovascular Catheter |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,070.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.